Skip to main content

Advertisement

SpringerLink
Log in

Resection of Invasive Pulmonary Aspergillosis in Immunocompromised Patients

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: Immunocompromised patients are prone to develop invasive pulmonary aspergillosis (IPA). Relapse and high mortality rates are seen in those patients who receive subsequent immunotoxic therapy. Standard antifungal regimens often fail to completely eradicate IPA, which then warrants an aggressive surgical approach.

Methods: We performed a retrospective chart review of 13 immunocompromised patients who were considered to have IPA and who underwent surgery between 1988 and 1998.

Results: Twelve patients had a hematological malignancy and one patient had breast cancer. The diagnosis of IPA was based on a chest computed tomographic scan in all patients. A preoperative diagnosis of aspergillosis was made in three patients, and mucormycosis in one patient, by bronchoalveolar lavage. Before surgery, seven patients received chemotherapy, one patient underwent bone marrow transplantation, and five patients received a combination of chemotherapy and bone marrow transplantation. Symptoms included cough (54%), fever (54%), hemoptysis (30%), and shortness of breath (8%). Three patients (23%) were asymptomatic. The mean preoperative absolute neutrophil count was 4881 cells/ml. Seventeen thoracic operations were performed, i.e., 12 wedge resections, 4 lobectomies, and 1 pneumonectomy. One patient also underwent nephrectomy for invasive aspergillosis and one patient underwent craniotomy to resect an aspergillus brain mass. Surgical pathology revealed IPA in 13 (76%), invasive mucormycosis in 2 (15%), aspergilloma in 1, and diffuse alveolar hemorrhage in 1. Postoperative complications included the following: operative bleeding requiring transfusion, three patients; prolonged air leak, two patients; death because of hepatic/renal failure, one patient; and death because of overwhelming multisystem aspergillosis, one patient. Seven (54%) patients underwent further immunotoxic treatment with no aspergillosis recurrence. After a mean follow-up of 12 months, five (38%) patients are alive and seven (54%) have died without evidence of aspergillosis and/or mucormycosis.

Conclusions: Surgical resection, in combination with antifungal agents, is a safe and effective form of therapy for invasive mycoses. It prevents recurrence and allows for subsequent cytotoxic therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. White DA, Santamauro JT. Pulmonary infections in immunocompromised patients. Curr Opin Pulm Med 1995;1:202–208.

    PubMed  CAS  Google Scholar 

  2. Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 1996;23:608–615.

    PubMed  CAS  Google Scholar 

  3. Kahn FW, Jones JM, Enland DM. The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis. Am J Clin Pathol 1986;86:518–523.

    PubMed  CAS  Google Scholar 

  4. von Eiff M, Roos N, Schulten R, Hesse M, Zuhlsdorf M, van de Loo J. Pulmonary aspergillosis: early diagnosis improves survival. Respiration 1995;62:341–347.

    Article  PubMed  CAS  Google Scholar 

  5. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998;26:781–805.

    CAS  PubMed  Google Scholar 

  6. Hinson KFW, Moon AJ, Plummer NS. Bronchopulmonary aspergillosis: review and report of eight cases. Thorax 1952;7:317–33.

    PubMed  CAS  Google Scholar 

  7. Albelda SM, Talbot GH, Gerson SL. Pulmonary cavitation and massive hemoptysis in invasive pulmonary aspergillosis in patients with acute leukemia. Am J Med 1985;79:57–64.

    Google Scholar 

  8. Pagano L, Ricci P, Nosari A. Fatal haemoptysis in pulmonary filamentous mycosis: an underevaluated cause of death in patients with acute leukaemia in hematological complete remission: a retrospective study and review of literature. Br J Haematol 1995;89:500–505

    PubMed  CAS  Google Scholar 

  9. Gerson SI, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Casileth PA. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med 1984;100:345–351.

    PubMed  CAS  Google Scholar 

  10. Robinson LA, Reed EC, Galbraith TA, Alonso A, Moulton AL, Fleming WH. Pulmonary resection for invasive aspergillus infections in immunocompromised patients. J Thorac Cardiovasc Surg 1995;109:1182–1197.

    PubMed  CAS  Google Scholar 

  11. Baron O, Guillaume B, Moreau P, et al. Aggressive surgical management in localized pulmonary mycotic and nonmycotic infections for neutropenic patients with acute leukemia: report of eighteen cases. J Thorac Cardiovasc Surg 1998;115:63–69.

    PubMed  CAS  Google Scholar 

  12. Reichenberger F, Habicht J, Kaim A, et al. Lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematologic diseases. Am J Respir Crit Care Med 1998;158:885–890.

    PubMed  CAS  Google Scholar 

  13. Caillot D, Casasnovas O, Bernard A, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997;15:139–147.

    PubMed  CAS  Google Scholar 

  14. Kuhlman JE, Fishman EK, Burch PA, Karp JE, Zerhouni EA, Siegelman SS. CT of invasive pulmonary aspergillosis. AJR 1988; 150:1015–1020.

    PubMed  CAS  Google Scholar 

  15. Hruban RH, Meziane MA, Zerhouni EA, Wheeler PS, Dumler JS, Hutchins GM. Radiologic-pathologic correlation of the CT halo sign in invasive pulmonary aspergillosis. J Comput Assist Tomogr 1987;11:534–536.

    PubMed  CAS  Google Scholar 

  16. Robertson MJ, Larson RA. Recurrent fungal pneumonias in patients with acute leukemia undergoing multiple courses of intensive chemotherapy. Am J Med 1988;87:233–239.

    Google Scholar 

  17. Liles WC, Huang JE, van Burik JA, Bowden RA, Da;e DC. Granulocyte colony-stimulating factor administered in vivo augments neutrophil activity against opportunistic fungal pathogens. J Infect Dis 1997;175:1012–1015.

    Article  PubMed  CAS  Google Scholar 

  18. Denning DW, Marinus A, Cohen J, et al. An EORTC multicentre prospective survey of invasive aspergillosis in haematologic patients: diagnosis and therapeutic outcome: EORTC Invasive Fungal Infections Cooperative Group. J Infect 1998;37:173–180.

    PubMed  CAS  Google Scholar 

  19. Moreau P, Jahar JR, Milpied N, et al. Localized invasive pulmonary aspergillosis in patients with neutropenia. Cancer 1993;72: 3223–3226.

    PubMed  CAS  Google Scholar 

  20. Bernard A, Caillot D, Couaillier JF, Casasnovas O, Guy H, Favre JP. Surgical management of invasive pulmonary aspergillosis in neutropenic patients. Ann Thorac Surg 1997;64:1441–1447.

    PubMed  CAS  Google Scholar 

  21. Salerno CT, Ouyang DW, Pederson TS, et al. Surgical therapy for pulmonary aspergillosis in immunocompromised patients. Ann Thorac Surg 1998;65:1415–1419.

    PubMed  CAS  Google Scholar 

  22. Pagano L, Ricci P, Tonso A, et al. Mucormycosis in patients with haematological malignancies: a retrospective study of 37 cases. Br J Haematol 1997;99:331–336.

    PubMed  CAS  Google Scholar 

  23. Tedder M, Spratt JA, Anstadt MP, Hedge SS, Tedder SD, Lowe JE. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg 1994;57:1044–1050.

    Article  PubMed  CAS  Google Scholar 

  24. Wingard JR, Mellits ED, Sostrin MB, et al. Interstitial pneumonitis after allogeneic bone marrow transplantation: nine-year experience at a single institution. Medicine (Baltimore) 1988;67:175–186.

    CAS  Google Scholar 

  25. Husni RN, Gordon SM, Longworth DL, et al. Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients. Clin Infect Dis 1998;26:753–755.

    PubMed  CAS  Google Scholar 

  26. Peterson PK, McGlave P, Ramsay NKC. A prospective study of infectious diseases following bone marrow transplantation: emergence of aspergillus and cytomegalovirus as the major causes of mortality. Infect Control 1983;4:81–89.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Thoracic Surgical Oncology, Roswell Park Cancer Institute, State University of New York at Buffalo, Buffalo, New York

    Ihor Pidhorecky MD, John Urschel MD & Timothy Anderson MD

  2. Department of Thoracic Surgical Oncology, Roswell Park Cancer Institute, State University of New York at Buffalo, Buffalo, NY, 14263

    Ihor Pidhorecky MD

Authors
  1. Ihor Pidhorecky MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John Urschel MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Timothy Anderson MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ihor Pidhorecky MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pidhorecky, I., Urschel, J. & Anderson, T. Resection of Invasive Pulmonary Aspergillosis in Immunocompromised Patients. Ann Surg Oncol 7, 312–317 (2000). https://doi.org/10.1007/s10434-000-0312-6

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10434-000-0312-6

Key Words

Search

Navigation